CD8A and neoplasm: In murine tumor models, the anti-PD-1 antibody can be transferred from CD8+PD-1+ T cells to PD-1− macrophages through FcγRIIb/III receptors and the same phenomenon can be reproduced in vitro with human cells and Nivolumab.